Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...
Beyond acromegaly treatment, the company is expanding its scope to include a Phase 3 trial for carcinoid syndrome and is reporting additional Phase 2 data for other drug candidates, such as atumelnant ...
B vitamins or B-complex vitamins is the name given to a group of eight nutrients that are involved in important processes within the body, including metabolism, energy production, and red blood cell ...